Phthalate esters are commonly used plasticizers; however, some are suspected to cause reproductive toxicity. Administration of high doses of di-(2-ethylhexyl) phthalate (DEHP) induces germ cell death in male rodents. Mono-(2-ethylhexyl) phthalate (MEHP), a hydrolyzed metabolite of DEHP, appears to be responsible for this testicular toxicity; however, the underlying mechanism of this chemical's action remains unknown. Here, using a one-step affinity purification procedure, we identified glycogen debranching enzyme (GDE) as a phthalate-binding protein. GDE has oligo-1,4-1,4-glucanotransferase and amylo-1,6-glucosidase activities, which are responsible for the complete degradation of glycogen to glucose. Our findings demonstrate that MEHP inhibits the activity of oligo-1,4-1,4-glucanotransferase, but not of amylo-1,6-glucosidase. Among various phthalate esters tested, MEHP specifically binds to and inhibits GDE. We also show that DEHP administration affects glycogen metabolism in rat testis. Thus, inhibition of GDE by MEHP may play a role in germ cell apoptosis in the testis.
Phthalate esters (e.g., di-(2-ethylhexyl) phthalate [DEHP] , di-n-butyl phthalate [DBP] , diethylphthalate [DEP] , and butyl benzyl phthalate [BBP] ) are widely used plasticizers. These esters are not covalently bound to polymer matrices and are thus readily released into the environment. Humans become exposed to phthalate esters via many industrial sources, including food wrap, medical devices and cosmetics.
Among phthalate esters, DEHP is one of the most heavily used and has been found to induce hepatomegaly and hepatocellullar carcinoma in rodents (Huber et al., 1996) . DEHP also has long been suspected to confer toxic effects on the reproductive organs in humans and animals (Foster et al., 2001; Latini et al., 2006; Matsumoto et al., 2008) . In rodents, DEHP induces embryonic lethality (Ema et al., 1997a; Tyl et al., 1988) and contributes to developmental disorders of the reproductive tract (Carruthers and Foster, 2005; Ema et al., 1997b; Gray et al., 2000) , particularly testicular atrophy (Oishi, 1985; Parmar et al., 1995; Shaffer et al., 1945; Sjoberg et al., 1986) . Oral administration of a single high dose of DEHP induces acute germ cell apoptosis in male rodents (Teirlynck et al., 1988) . Previous studies have shown that DEHP is rapidly metabolized to mono-(2-ethylhexyl) phthalate (MEHP) in the gastrointestinal tract (Albro and Thomas, 1973; Daniel and Bratt, 1974) , conferring toxicity to the liver and testis (Sjoberg et al., 1986; Teirlynck et al., 1988) . It has been shown that in rodents, MEHP binds and activates peroxisome proliferator-activated receptors (PPARs), and most of the responses to DEHP and MEHP in the liver are dependent on PPAR-a, a member of the PPAR family of nuclear receptors (Klaunig et al., 2003; Ward et al., 1998) . In contrast, DEHP induces testicular toxicity even in PPAR-a-null mice (Ward et al., 1998) , indicating that a PPAR-a-independent mechanism is sufficient to account for the toxicity of DEHP in the testis. Previous reports showed that Sertoli cells are one of the primary targets of DEHP and MEHP in the testis (Lee et al., 1997; Li et al., 1998 Li et al., , 2000 Richburg and Boekelheide, 1996; Troiano et al., 1994) , but the molecular mechanisms of their toxicity remain elusive.
Here, we demonstrate that glycogen debranching enzyme (GDE) is a cellular target of MEHP. Along with glycogen phosphorylase, GDE is required for the complete degradation of glycogen to glucose (Fig. 1) . Glycogen phosphorylase catalyzes the release of glucose-1-phosphate from the nonreducing ends of glycogen, but is incapable of removing glucose residues from the branch points (a-1,6 linkages). Branch point glucose residues are then removed by GDE. GDE 1 These authors contributed equally to the work. 2 To whom corresponding should be addressed at Integrated Research Institute, Tokyo Institute of Technology, Yokohama, possesses two catalytic activities, oligo-1,4-1,4-glucanotransferase (hereafter referred to as 1,4-transferase) and amylo-1,6-glucosidase (referred to as 1,6-glucosidase), that eliminate the a-1,6-branch point of glycogen by transferring a maltosyl (or maltotriosyl) group to an adjacent main chain and subsequently hydrolyzing the exposed a-1,6-glucosyl stub (Bates et al., 1975; Taylor et al., 1975) . Here, we show that MEHP binds directly to GDE and inhibits its 1,4-transferase activity, affecting glycogen metabolism in rat testis. These findings suggest that GDE might be responsible for the reproductive toxicity of the phthalate ester.
MATERIALS AND METHODS
Affinity purification. Latex beads used in affinity purification (SGNEGDE beads) were prepared as previously described (Shimizu et al., 2000) . An aminoderivative of diethyl phthalate (DEP) (see Fig. 2A ) (20 lmol, synthesized by Shimadzu, Kyoto, Japan) was immobilized in 10 mg of beads via incubation in 1 ml of 60% methanol at 37°C for 96 h in the dark. Unreacted phthalate ester derivative was removed by washing the beads three times with 60% methanol, followed by centrifugation (14,000 g, 4°C, for 5 min). Nuclear extracts were prepared from HeLa cells as previously described (Dignam et al., 1983) . Phthalate-immobilized beads (0.5 mg) were equilibrated with buffer D (20mM HEPES, pH 7.9, 10% glycerol, 1mM MgCl 2 , 0.2mM ethylenediaminetetraacetic acid [EDTA], 1mM dithiotreitol [DTT], 1mM PMSF, and 0.1% NP-40) containing 50mM KCl. The beads were then incubated with 1 mg (200 ll) of nuclear extracts for 2 h on ice, with occasional tapping. After washing the beads three times with 500 ll of buffer D, bound proteins were eluted in 30 ll of buffer D containing 1M KCl and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by silver staining.
Recombinant GDE expression and binding assay. The cDNA encoding human GDE was obtained by RT-PCR and inserted into the pET14b vector (Novagen) containing a 5# Flag-tag. The pET14b-based plasmids encoding deletion mutants of GDE (del-1 to del-7) were constructed via restriction enzyme digestion and PCR. A recombinant GDE protein was expressed in Escherichia coli and purified by nickel affinity chromatography (Novagen), according to the manufacturer's instructions. For binding assays, 0.1 mg of equilibrated phthalate-immobilized beads was incubated with 6 pmol of recombinant proteins on ice for 2 h. After washing the beads three times with 500 ll of buffer D (containing 100mM of KCl), the bound proteins were eluted in SDS sample buffer and analyzed by SDS-PAGE, followed by immunoblotting with an anti-His antibody (Qiagen).
GDE activity assays. Recombinant GDE (100 ng) was preincubated with vehicle (5% ethanol), phthalate esters (DEP, DBP, DEHP, MEP, MBP, or MEHP) or Nojirimycin (Noji) in reaction buffer (25mM citrate, pH 6.5, 5mM EDTA, 1mM CaCl 2 , 0.1mM DTT, and 2% ethanol) for 1 h at 37°C. To measure total GDE activity (1,4-transferase and 1,6-glycosidase activities), 0.5% limit dextrin was added to the reaction and the mixture was incubated at 37°C for 60 min. The released glucose was then quantified using the Glucose (HK) Assay Kit (Sigma), according to the manufacturer's instructions. The activity of 1,4-transferase was measured as previously described (Nelson et al., 1970) . Briefly, GDE was HeLa cell extracts were subjected to affinity purification using DEPfixed latex beads. Unligated latex beads were used as a control (lane 1). After extensive washes with buffer containing the indicated concentrations of KCl (lanes 2-7), bound proteins were eluted in a buffer containing 1M KCl, followed by SDS-PAGE and silver staining analyses. Among the specific binding proteins identified (indicated by arrowheads), a protein of 150 kDa (indicated by an arrow) was the most resistant to high salt conditions. This protein was determined to be GDE via subsequent protein microsequencing. combined with dextrin in the reaction buffer. A 10-ll aliquot was then transferred to a siliconized tube and combined with 10 ll of 0.2M HCl and 130 ll of iodine reagent (0.4mM I 2 , 6.2mM KI, 7.4M CaCl 2 ). The dextran concentration was determined by measuring the increase in absorbance at 500 nm. To measure 1,6-glucosidase activity, GDE was incubated with 40mM mono-6-O-a-glucosyl-bcyclodextrin in the reaction buffer and the amount of released glucose was quantified. Throughout the experiments, we used high doses of phthalate esters and did not measure contaminating phthalate esters in water and reagents.
For expression of GDE in COS-1 cells, the HA-and Flag-tagged full-length cDNA fragments of GDE were inserted into a pcDNA3 vector (Invitrogen, Carlsbad, CA) to make pcDNA3/HA-FLAG-GDE. COS-1 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. 2 3 10 5 COS-1 cells grown in a 60-mm dish were transfected with 6.4 lg of pcDNA3/HA-FLAG-GDE plasmid using the calcium phosphate method. The medium was changed 12 h after transfection, MEHP, DEHP or Noji were added, and cells were further incubated for 24 h. Cytosolic extract was prepared as previously described (Dignam et al., 1983) and assayed for total GDE activity as described above.
SPR analysis. The kinetics of the interaction between GDE and the phthalate ester were analyzed by SPR using a BIACORE3000 (GE Healthcare). To avoid steric hindrance, tetraglycine (Sigma) was immobilized on the activated Sensor Chip CM5 in immobilization buffer (50mM borate, pH 8.5, and 1M NaCl) and unreacted tetraglycine was washed with 1M ethanolamine. After activation of the tetraglycine carboxyl group using the Amine Coupling Kit (Biacore), 3mM of the aminoderivative of DEP was coupled in immobilization buffer and unreacted carboxyl groups were inactivated by the addition of 1M ethanolamine. Various concentrations of recombinant GDE del-7 protein were added to the running buffer (20mM HEPES pH 7.9, 100mM KCl, 1mM MgCl 2 , 0.2mM EDTA, 1mM DTT, 0.01% NP-40, and 5% ethanol) and injected over the sensor surface. The sensorgram was then analyzed using BIAevaluation software version 3.0 (Biacore).
Histochemistry. Antiserum against GDE was obtained by immunizing rabbits with recombinant His-Flag-tagged GDE protein with an internal deletion (amino acids 481-1468) produced in E. coli. The antiserum was used without affinity purification or IgG fractionation. Five-week-old male Wistar rats received oral DEHP (2 g per kg body weight) or a vehicle (corn oil). After 12 or 24 h, the testes and the liver were dissected, fixed with 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4) at 4°C for 12 h, and embedded in paraffin. Sections were prepared and immunostained with anti-GDE serum (at a 1/100 dilution) as previously described (Ozawa et al., 2002) . The ApopTag Plus Peroxidase In Situ Apoptosis Kit (Millipore) was used for terminal dUTP nick end labeling (TUNEL) staining. Total liver extract was prepared by homogenizing the tissue in buffer D and cleared by centrifugation at 14,000 g for 5 min. 0.4 lg of the extract was separated by SDS-PAGE, transferred to a polyvinylidene difluoride membrane and blotted with anti-GDE antiserum (at a 1/100 dilution). All animal protocols were approved by the Animal Care Committee of the Keio University School of Medicine, in accordance with institutional guidelines.
Metabolome analysis. Five-week-old male Wistar rats were administered oral DEHP (2 g per kg body weight) or a vehicle (corn oil). After 24 h, rats were anesthetized via an i.p. injection of Nembutal and the testes were dissected and immediately frozen. Metabolite extraction, instrumentation and conditions for metabolome analysis have been described previously (Soga et al., 2006) .
Statistical analysis.
Values are expressed as means ± SEM, and data were analyzed using one-way ANOVA.
RESULTS

Identification of GDE as a Phthalate Ester-Binding Protein
To explore the adverse effects of phthalate esters, we searched for proteins that interact with phthalate ester using one-step affinity chromatography with high-performance latex beads composed of glycidylmethacrylate (GMA)-covered GMA-styrene copolymer ( Fig. 2A) (Shimizu et al., 2000) . The beads were covalently immobilized with a DEP derivative that contained an amino group at the end of one of the alkyl chains and were subsequently used to purify putative phthalate ester-binding proteins. Several candidate proteins were purified from extracts from the human cervical carcinoma HeLa cell line (Fig. 2B) . One protein, with a molecular weight of 150 kDa, maintained a stable association with the beads even at high salt concentrations. Large-scale purification and protein microsequencing revealed the 150-kDa protein to be GDE.
The direct binding of GDE to the phthalate ester-immobilized beads was confirmed by using recombinant full-length GDE (1532 amino acids) purified from E. coli (Figs. 3A and 3B ). To gain more insight into the structural requirement of GDE for phthalate binding, a series of deletion mutants of GDE was constructed (Fig. 3A) . Using these mutants, we found that the amino-terminal region of GDE (amino acids 121-189) is required for binding (Fig. 3B ). This region overlaps with a conserved amino-terminal a-amylase domain that has been shown to convey 1,4-transferase activity (Nakayama et al., 2001) . On the other hand, its 1,6-glucosidase activity has been mapped to its carboxyl-terminal half which is not required for binding to the ester (Nakayama et al., 2001) .
MEHP Specifically Inhibits the 1,4-Transferase Activity of GDE We next examined the effects of phthalate esters on the enzymatic activities of GDE. Purified full-length recombinant GDE was assayed for total glycogen debranching activity (1,4-transferase and 1,6-glucosidase activity) in the presence of various phthalate esters (Fig. 4A) . Noji, an antibiotic that acts as a broad range a-glucosidase inhibitor (Niwa et al., 1972) , was used as a positive control. Among the phthalate esters tested, MEHP decreased GDE activity, whereas the other phthalate esters (including DEP and DEHP) had minimal effects, even at doses of 1mM.
In spite of the fact that DEP derivative was used for affinity purification (Fig. 2) , DEP did not inhibit GDE activity. To test whether DEP and MEHP bind GDE, the interaction of GDE and the phthalate esters was analyzed by surface plasmon resonance. The amino derivative of DEP that had been used for affinity purification was immobilized onto the sensor chip surface and real-time interaction with an increasing amount of recombinant GDE protein (Del-7, Fig. 3A ) was analyzed. The sensorgram of the association and dissociation phases indicated that GDE interacted stoichiometrically with the DEP-immobilized sensor chip (Fig. 5A) . Preincubation of MEHP competed against the association of GDE with the DEP-immobilized sensor chip in a dose-dependent manner (Fig. 5B) , whereas DEP did not, even at a concentration of 5mM (Fig. 5C ). These results indicate that MEHP binds to GDE with a higher affinity than DEP.
PHTHALATE ESTER MEHP INHIBITS GLYCOGENOLYSIS
To determine which GDE activity is targeted by the phthalate ester, 1,4-transferase and 1,6-glucosidase activities were assayed separately. As shown in Figure 4B , MEHP specifically inhibited 1,4-transferase activity, but not 1,6-glucosidase activity, in a dose-dependent manner (Fig. 4B) .
We also examined the inhibition of GDE activity by MEHP in living cells. We transfected COS-1 cells with an expression vector for Flag-tagged GDE and treated the cells with MEHP, DEHP, or Noji for 24 h. Cell extracts were then prepared and assayed for GDE activity. Prior treatment of COS-1 cells with MEHP significantly inhibited cellular GDE activity, with little effect on enzyme expression (Fig. 6 ). Again, DEHP had a minimal effect on GDE activity. Taken together, these results indicate that MEHP is a specific inhibitor of GDE.
DEHP Affects Glycogen Metabolism in Rat Testis
These findings prompted us to determine if MEHP modulates glycogen metabolism in vivo. Thus, we performed a metabolome analysis of rats following the oral administration of DEHP or a vehicle control. Metabolites were extracted from rat testis and metabolic intermediates of glycogen metabolism and the glycolytic pathway were quantified (Table 1) . As expected, MEHP (the hydrolyzed product of DEHP) accumulated in the testis. Among the metabolites tested, glucose-1-phosphate (G1P), which is produced from glycogen (via phosphorolysis by glycogen phosphorylase) or from glucose-6-phosphate (G6P) (via transfer of a phosphate group by phosphoglucomutase), was significantly decreased by DEHP in the testis. The concentrations of glycolytic intermediates (G6P, fructose-6-phosphate, fructose-1,6-diphosphate, 3-phosphoglycerate, and phosphoenolpyruvate) were not significantly changed. The amount of UDP-glucose, a substrate for glycogen synthase to produce glycogen, was also not changed. Thus, the specific reduction of G1P suggests that DEHP appears to affect glycogenolysis in rat testis.
To test whether GDE is expressed in the testis, we sought to examine the distribution of GDE in rat testis via immunohistochemistry. An anti-GDE antiserum was raised against recombinant GDE protein purified from E. coli. The specificity of the antiserum was analyzed by Western blotting of total liver His-FLAG-tagged full-length (FL) GDE and a series of GDE deletion mutants (del-1 to del-7) were purified from E. coli and subjected to binding assays using DEP-immobilized latex beads. Proteins that bound to the beads (À, beads alone; þ, phthalate ester-fixed beads) and 2% of input were blotted using an anti-His antibody.
extract. A single protein with a molecular weight of 150 kDa that corresponds to the molecular weight of GDE was detected (Fig. 7A) . Using a rat liver section, the cytoplasm of hepatocytes, particularly around the central veins where glycogen metabolism is active, was stained with the anti-GDE serum (Fig. 7B) . Next, a section of rat testis was stained with the anti-GDE serum. Signals in the cytoplasm of germ cells of the rat testis were observed (Fig. 7C, left and right) . In particular, crescent-shaped signals were observed in the acrosomes of differentiated germ cells (elongated spermatids) as well as in the pre-acrosomal region of round spermatids. Oral administration of DEHP did not induce an appreciable change in GDE expression in rat testis (Fig. 7C, middle ). An increase in germ cell apoptosis within the seminiferous tubules by DEHP administration was confirmed by TUNEL staining (Figs. 7D and 7E ). Although it is not clear that glycogenolysis is active in spermatids, these results suggest that inhibition of GDE may play a role in DEHP-induced apoptosis in the testis.
DISCUSSION
Our findings reveal that MEHP specifically binds to GDE and inhibits 1,4-transferase activity in vitro and in cell culture. We also demonstrated that DEHP administration decreases the amount of G1P in rat testis, which is indicative of impaired glycogenolysis. As GDE is required for the complete degradation of glycogen to glucose, we propose that DEHP/ MEHP modulates glycogenolysis in testis via the inhibition of GDE .   FIG. 4 . MEHP inhibits the 1,4-transferase activity of GDE. (A) Specific inhibition of total GDE activity by MEHP. Purified recombinant GDE (100 ng) was assayed for its ability to release glucose from dextrin in the presence of 1mM phthalate esters or Noji. The structures of DEP, DBP, and DEHP, in addition to their metabolites MEP, MBP, and MEHP are shown on the right. (B) Inhibition of the 1,4-transferase activity of GDE by MEHP. The 1,4-transferase (middle panel) and 1,6-glucosidase (right panel) activities of recombinant GDE were assayed separately in the presence of increasing doses of MEHP. The combined GDE activity was also measured as in A (left panel). The enzymatic activity in the experimental condition described in the Materials and Methods without drugs was set at 100 and the data are presented as relative activities (%).
PHTHALATE ESTER MEHP INHIBITS GLYCOGENOLYSIS
We purified and identified GDE using latex beads that were immobilized with an amino-derivative of DEP. However, DEP did not inhibit GDE activity nor did it compete with its binding to a DEP-immobilized sensor chip in SPR analysis, probably because the amino group and/or linker attached to this molecule might enhance GDE binding. Instead, among the phthalate esters tested, MEHP specifically competed for binding of GDE to the DEP-immobilized sensor chip in SPR analysis (Fig. 5) and inhibited its 1,4-transferase activity in vitro (Fig. 4) and in cell culture (Fig. 6) . These results are consistent with our finding that GDE binds to the phthalate ester via the amino-terminal 1,4-transferase domain (Fig. 3) . Taken together, these results indicate that MEHP binds to the amino-terminal domain of GDE and inhibits its 1,4-transferase activity.
We detected anti-GDE immunoreactivity in male germ cells by section immunostaining. The immunoreactivity was the strongest in the acrosomes where unspecific signal is often detected. Although we did not detect immunoreactivity using preimmune serum, more careful examination is required to conclude that GDE is expressed in the acrosomes. Given that GDE is expressed in the germ cells, however, it has been reported that spermatids do not use glucose as their energy source, and that Sertoli cells metabolize glucose and supply pyruvate and lactate to the spermatids (Grootegoed et al., 1984; Mita and Hall, 1982; Robinson and Fritz, 1981) . Therefore, it seems plausible that glycogenolysis by GDE in the spermatids, if any occurs, may have little role in those cells' energy supply and viability. However, our metabolome analyses demonstrate a small but significant decrease in the G1P levels of DEHPtreated rat testis, suggesting that glycogen metabolism is affected, although this modest decrease in the G1P level does not necessarily explain the testicular toxicity of DEHP. Therefore, it is possible that MEHP might inhibit GDE and glycogenolysis in the Sertoli cells. Previous reports have shown that Sertoli cells are the primary targets of DEHP/ MEHP testicular toxicity and germ cell apoptosis (Lee et al., 1997 (Lee et al., , 1998 (Lee et al., , 2000 Richburg and Boekelheide, 1996; Troiano et al., 1994) . It has been demonstrated that in Sertoli cells, DEHP/MEHP induces FasL expression (Lee et al., 1997; Richburg et al., 1999) , alters Vimentin filaments (Richburg and Boekelheide, 1996) , decreases CyclinD2 expression (Li et al., 2000) and inhibits Gap junctional intercellular communication (Kang et al., 2002) . Although these alterations have been shown to be associated with germ cell apoptosis, direct target molecule of MEHP remains unknown. We propose that GDE inhibition in the Sertoli cells may play some roles in the process of germ cell apoptosis by DEHP/MEHP. It remains to be determined whether Sertoli cells express GDE, and further studies of glycogen metabolism in the testis are needed to clarify the effects of DEHP/MEHP on reproductive toxicity.
Human genetic disorders of glycogen metabolism are collectively referred to as glycogen storage diseases (GSDs) and are known to affect the liver and muscle tissues. Genetic 
deficiencies in human GDE can lead to the development of GSD type III (GSD-III or Cori's disease), which is characterized by hepatomegaly, variable myopathy, cardiomyopathy, and hypoglycemia (Shen and Chen 2002; Van Hoof and Hers, 1967) . Thus, GDE clearly plays an important role in glycogen metabolism in the liver and muscle. However, as far as we know, there have been no reports of male germ cell deficiencies in patients with GSD-III. We have observed that in contrast to rat testis, glycogen metabolism in the liver was not significantly affected by DEHP treatment (data not shown) in spite of the fact that larger amounts of MEHP were accumulated in the liver (38.8 nmol/g tissue) than in the testis (17.4 nmol/g). Given that MEHP modulates glycogen metabolism via the inhibition of GDE, we sought to determine why DEHP might exert such insignificant effects on liver, a major site of glycogen metabolism. Our preliminary data showed that the amounts of GDE protein in liver and muscle are approximately 25 and 50 times higher than that in the testis, respectively (data not shown). Therefore, the DEHP concentration used in this study may not have been sufficient to inhibit the elevated GDE activity in the liver. Conversely, testis may be one of the most sensitive sites to DEHP because it expresses only a small amount of GDE.
Our demonstration that MEHP is a specific inhibitor of GDE provides novel insights into the molecular mechanisms of this widely used chemical, including its toxicity to the reproductive system and to cellular metabolism. Furthermore, our strategy for isolating chemical-binding proteins can be applied to other putative toxic compounds or to endocrine-disrupting chemicals. Results from such studies may help elucidate the mechanisms of action and risks of various compounds. 
